BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2025 8:08:13 AM | Browse: 96 | Download: 125
 |
Received |
|
2025-07-01 01:09 |
|
Peer-Review Started |
|
2025-07-01 01:09 |
|
First Decision by Editorial Office Director |
|
2025-07-19 02:16 |
|
Return for Revision |
|
2025-07-19 02:16 |
|
Revised |
|
2025-07-30 07:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-16 02:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-16 06:32 |
|
Articles in Press |
|
2025-09-16 06:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-21 01:47 |
|
Publish the Manuscript Online |
|
2025-10-27 08:08 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aneta Sokal-Dembowska, Kübra Ergan and Sara Jarmakiewicz-Czaja |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sara Jarmakiewicz-Czaja, PhD, Researcher, Faculty of Health Sciences and Psychology, Collegium Medicum, University of Rzeszow, Kopisto 2a, Rzeszow 35-959, Poland. sjczaja@ur.edu.pl |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Inflammatory bowel disease; Gut microbiota; Inflammation; Liver-gut axis; Oxidative stress |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease (MASLD) in inflammatory bowel disease (IBD) may share a common denominator with the gut microbiota. Through various factors, such as environmental factors, intestinal dysbiosis can occur, disrupting the homeostasis of the intestinal barrier and the entry of, for example, bacterial metabolites that exacerbate inflammation in the body. In the review, we analysed the various pathogenetic mechanisms of MASLD in IBD with an emphasis on the role of the gut microbiota. |
| Publish Date |
2025-10-27 08:08 |
| Citation |
Sokal-Dembowska A, Ergan K, Jarmakiewicz-Czaja S. Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease. World J Gastroenterol 2025; 31(40): 111375 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i40/111375.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i40.111375 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
